These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11370534)

  • 21. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
    Garcia-Rostan G; Zhao H; Camp RL; Pollan M; Herrero A; Pardo J; Wu R; Carcangiu ML; Costa J; Tallini G
    J Clin Oncol; 2003 Sep; 21(17):3226-35. PubMed ID: 12947056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.
    Lemoine NR; Mayall ES; Wyllie FS; Williams ED; Goyns M; Stringer B; Wynford-Thomas D
    Oncogene; 1989 Feb; 4(2):159-64. PubMed ID: 2648253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Somatic genetics of breast cancer].
    Bièche I; Lidereau R
    Bull Cancer; 1997 Jan; 84(1):83-96. PubMed ID: 9180865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular pathways of pancreatic carcinogenesis].
    Torrisani J; Buscail L
    Ann Pathol; 2002 Oct; 22(5):349-55. PubMed ID: 12483152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
    Sakorafas GH; Tsiotou AG; Tsiotos GG
    Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes.
    Zitzelsberger H; Thomas G; Unger K
    Mol Cell Endocrinol; 2010 May; 321(1):57-66. PubMed ID: 19961897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis.
    Aldred MA; Ginn-Pease ME; Morrison CD; Popkie AP; Gimm O; Hoang-Vu C; Krause U; Dralle H; Jhiang SM; Plass C; Eng C
    Cancer Res; 2003 Jun; 63(11):2864-71. PubMed ID: 12782592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biology of solid cancers: breast cancer as an example. First part: genetic systems implicated in carcinogenesis].
    Bièche I; Lidereau R
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):131-41. PubMed ID: 8690861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cell cycle and carcinogenesis].
    Solé Balcells F
    Ann Urol (Paris); 1995; 29(5):271-9. PubMed ID: 8638907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics of thyroid tumors and surgical decision-making.
    Learoyd DL; Messina M; Zedenius J; Robinson BG
    World J Surg; 2000 Aug; 24(8):923-33. PubMed ID: 10865036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyrotropin receptor: a role for thyroid tumourigenesis?
    Russo D; Arturi F; Chiefari E; Filetti S
    Forum (Genova); 1999; 9(2):166-75. PubMed ID: 10385711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [From the cytogenetics to the cytogenomics of thyroid tumors].
    Perissel B; Bernheim A; Couturier J; Fouilhoux G; Vago P
    Bull Cancer; 2002 Jun; 89(6):588-92. PubMed ID: 12135859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medullary thyroid carcinoma and some of its particularities].
    Sidibé el H
    Sante; 2007; 17(1):51-5. PubMed ID: 17897902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Identification of oncogenes and anti-oncogenes].
    Thomas G
    Pathol Biol (Paris); 1995 Mar; 43(3):143-9. PubMed ID: 7675540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.
    Sandrini F; Matyakhina L; Sarlis NJ; Kirschner LS; Farmakidis C; Gimm O; Stratakis CA
    Genes Chromosomes Cancer; 2002 Oct; 35(2):182-92. PubMed ID: 12203783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.